Effect of rheumatologist education on systematic measurements and treatment decisions in rheumatoid arthritis: The metrix study

Journal of Rheumatology

Volumn 39, Issue 12, 2012, Pages 2247-2252

  Pope, Janet ^a   Thorne, Carter ^b   Cividino, Alfred ^c   Lucas, Kurt ^d  

^a ST JOSEPH S HEALTH CENTRE   (Canada)

^b SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Extension Marketing   (Canada)

Author keywords

Chart audit; Comparative feedback; Education; Knowledge translation exchange; Rheumatoid arthritis; Small group learning

Indexed keywords

BIOLOGICAL PRODUCT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; RHEUMATOID FACTOR; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL DISEASE ACTIVITY INDEX; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; DISEASE DURATION; EVIDENCE BASED MEDICINE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERNET; MALE; MEDICAL AUDIT; MEDICAL EDUCATION; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SCORING SYSTEM; SIMPLIFIED DISEASE ACTIVITY INDEX; TREATMENT RESPONSE;

ARTHRITIS, RHEUMATOID; DECISION MAKING; FEMALE; GROUP PROCESSES; HEALTH RECORDS, PERSONAL; HEALTH STATUS; HUMANS; MALE; MEDICAL AUDIT; PATIENT EDUCATION AS TOPIC; PROFESSIONAL PRACTICE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 84870384795     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120597     Document Type: Article

References (17)

1. Smolen JS, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: Recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.
2. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004;364:263-9. (Pubitemid 38942816)
3. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis Rheum 2005;52:3381-90. (Pubitemid 41612204)
4. Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AHM, Schenk Y, ter Borg EJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: Aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443-9. (Pubitemid 350032650)
5. Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18. (Pubitemid 27351112)
6. Fransen J, Moens HB, Speyer I, van Riel PL. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: A multicentre, cluster randomised controlled trial. Ann Rheum Dis 2005;64:1294-8. (Pubitemid 41206245)
7. van Vollenhoven RF, Ernestam S, Geborek P, Petersson IF, Cöster L, Waltbrand E, et al. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. Lancet 2009;374:459-66.
8. Moreland LW, O'Dell JR, Paulus H, Curtis JR, Bridges SL, Zhang X, et al. TEAR: Treatment of aggressive RA; a randomized, double-blind, 2-year trial comparing immediate triple DMARD versus MTX plus etanercept to step-up from initial MTX monotherapy [abstract]. Arthritis Rheum 2009;60 Suppl:1895.
9. Pope J, Thorne C, Haraoui BP, Sampalis JS. Treating to target with TNFi in active established RA results in longer drug survival than routine care with TNFi: Results from the Optimization of Humira RCT [abstract]. Arthritis Rheum 2010;62 Suppl:S144.
10. McKeown E, Bykerk VP, De Leon F, Thorne C, Hitchon CA, Boire G, et al. Quality assurance study of the use of preventative therapies in glucocorticord induced osteoporosis (GIOP) in early inflammatory arthritis (EIA): Results from the CATCH Cohort [abstract]. Arthritis Rheum 2010;62 Suppl:S406.
11. Pope J, Harding S, Khimdas S, Bonner A, Baron M, Canadian Scleroderma Research Group. An analysis of agreement with guidelines for management in SSc from a large database (CSRG: Canadian Scleroderma Research Group) [abstract]. Arthritis Rheum 2010;62 Suppl:S503.
12. Jamtvedt G, Young JM, Kristoffersen DT, O'Brien MA, Oxman AD. Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. Qual Saf Health Care 2006;15:433-6. (Pubitemid 46025156)
13. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995;274:700-5.
14. Lomas J, Enkin M, Anderson GM, Hannah WJ, Vayda E, Singer J. Opinion leaders vs audit and feedback to implement practice guidelines. Delivery after previous cesarean section. JAMA 1991;265:2202-7.
15. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45. (Pubitemid 10164318)
16. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;39:44-8.
17. Aletaha D, Nell VP, Stamm T, Uffman M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: Validation of a clinical activity score. Arthritis Res Ther 2005;7:R796-806.